Damora Therapeutics, Inc. GLTO
Set alert
21.58 USD 0.00 0.00%
As of Jun 4, 12:02 PM ET
21.58 Day range 23.54
52-week range unavailable
- YTD
- -6.21%
- 1 year
- +659.86%
- Open
- 22.26
- Prev close
- 21.58
- Mkt cap
- 34.47M
- Vol
- 609
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 21.58
- High
- 23.54
- Forward P/E
- -0.25
- Beta
- 1.25
- Short ratio
- 1.08
- Inst. own
- 12.03%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.25
- 200-d avg
- 12.56
- 1y target
- 10.00
Analyst view
Consensus: none
Price target (mean) 10.00
Ratings (0m) 1 1 buy · 0 hold · 0 sell
- Strong buy0
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 1
- 1 month ago 1
- 2 months ago 1
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -2.82 | -2.82 – -2.82 | -4.76 | +40.8% | 0 | 0.0% | 1 |
| Next quarter | 0.00 | 0.00 – 0.00 | -5.00 | 0.0% | 0 | 0.0% | 0 |
| Current year | -15.59 | -15.59 – -15.59 | -32.75 | +52.4% | 0 | 0.0% | 1 |
| Next year | -16.03 | -16.03 – -16.03 | -15.59 | -2.8% | 0 | 0.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 17, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Jun 10, 2024 | Oppenheimer | Maintained | Outperform | Outperform |
| Sep 28, 2023 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Aug 21, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 15, 2023 | SVB Leerink | Downgrade | Outperform | Market Perform |
| Aug 1, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| Aug 1, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jun 20, 2023 | Oppenheimer | Initiated | — | Outperform |
| May 24, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| May 15, 2023 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 17, 2023 | Cantor Fitzgerald | Initiated | — | Overweight |
| Mar 10, 2023 | Credit Suisse | Reiterated | — | Outperform |
| Aug 3, 2022 | SVB Leerink | Maintained | — | Outperform |
| Aug 6, 2021 | Credit Suisse | Maintained | — | Outperform |
| Mar 16, 2021 | Credit Suisse | Maintained | — | Outperform |
| Mar 16, 2021 | SVB Leerink | Maintained | — | Outperform |
| Nov 23, 2020 | Credit Suisse | Initiated | — | Outperform |
| Nov 23, 2020 | B of A Securities | Initiated | — | Buy |
| Nov 23, 2020 | SVB Leerink | Initiated | — | Outperform |